top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


The Enormous Impact of EVA/PCD Chemosensitivity Testing in Patients with Rare Cancers: Durable Benefit Provided by An Unexpected Recommendation
The drug we recommended, Pazopanib, would not normally be expected to have activity in this rare and aggressive cancer.

Dr. Robert A. Nagourney, MD
Nov 32 min read


With Cancer You Actually Can Teach an Old Dog a New Trick
In the Indian study of over 3200 subjects, trained dogs were used to detect cancer by smelling the breath of patients with biopsy proven cancers. Controls were all healthy volunteers.

Dr. Robert A. Nagourney, MD
Aug 122 min read


Ovarian Cancer - Stage III: Marcia Scheidler
Dr. Robert Nagourney was interviewed on the show “Extra”. He is having higher than normal results in treating cancer, with good outcomes.

Dr. Robert A. Nagourney, MD
Mar 29, 20232 min read
bottom of page
